Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

November 01, 2017; Volume 14,Issue 4

Editorial

  • You have access
    A race to uncover a panoramic view of primary liver cancer
    Ruidong Xue, Jing Li, Fan Bai, Xinwei Wang, Junfang Ji and Yinying Lu
    Cancer Biology & Medicine November 2017, 14 (4) 335-340; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0112
  • You have access
    The ascent of immune checkpoint inhibitors: is the understudy ready for a leading role?
    Amy L. Cummings and Edward B. Garon
    Cancer Biology & Medicine November 2017, 14 (4) 341-347; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0090

Review

  • You have access
    Cell cycle regulation and anticancer drug discovery
    Jingwen Bai, Yaochen Li and Guojun Zhang
    Cancer Biology & Medicine November 2017, 14 (4) 348-362; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0033
  • You have access
    Camptothecin-based nanodrug delivery systems
    Yan Wen, Yingze Wang, Xiaoli Liu, Wei Zhang, Xinhe Xiong, Zhongxiao Han and Xingjie Liang
    Cancer Biology & Medicine November 2017, 14 (4) 363-370; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0099

Original Article

  • You have access
    Brain metastasis in advanced colorectal cancer: results from the South Australian metastatic colorectal cancer (SAmCRC) registry
    Gonzalo Tapia Rico, Timothy J. Price, Christos Karapetis, Cynthia Piantadosi, Rob Padbury, Amitesh Roy, Guy Maddern, James Moore, Scott Carruthers, David Roder and Amanda R. Townsend
    Cancer Biology & Medicine November 2017, 14 (4) 371-376; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0068
  • You have access
    Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer
    Rongna Ma, Nannan Feng, Xiao Yu, Hongyan Lin, Xiaohong Zhang, Oumin Shi, Huan Zhang, Shuo Zhang, Lei Li, Min Zheng, Ming Gao, Herbert Yu and Biyun Qian
    Cancer Biology & Medicine November 2017, 14 (4) 377-386; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0061
  • You have access
    Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs
    Sumadi Lukman Anwar, Wahyu Wulaningsih and Johnathan Watkins
    Cancer Biology & Medicine November 2017, 14 (4) 387-395; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0050
  • You have access
    Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism
    Alexandra Giatromanolaki, Konstantina Balaska, Dimitra Kalamida, Christos Kakouratos, Efthimios Sivridis and Michael I. Koukourakis
    Cancer Biology & Medicine November 2017, 14 (4) 396-404; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0089
  • You have access
    Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension
    Filiz Kisaayak Collak, Ummuhan Demir, Seyma Ozkanli, Esra Kurum and Pinar Engin Zerk
    Cancer Biology & Medicine November 2017, 14 (4) 405-413; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0083

Case Report

  • You have access
    Complete pathologic response after chemoradiotherapy in a patient with rectal squamous cell carcinoma: a case report
    Zaied Sonia, Daldoul Amira, Bhiri Hanene, Ammar Nouha, Khechine Wiem, Toumi Omar, Abbes Ibtissem, Ben Salem Amina, Njima Manel and Mhabrech Houda
    Cancer Biology & Medicine November 2017, 14 (4) 414-417; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0010
  • You have access
    Brain metastasis in non-small cell lung cancer (NSCLC) patients with uncommon EGFR mutations: a report of seven cases and literature review
    Puchun Er, Tian Zhang, Jing Wang, Qingsong Pang and Ping Wang
    Cancer Biology & Medicine November 2017, 14 (4) 418-425; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0079
Back to top
PreviousNext

In this issue

Cancer Biology and Medicine: 14 (4)
Cancer Biology & Medicine
Vol. 14, Issue 4
1 Nov 2017
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article
  • Case Report

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire